Product Information
KEVZARA 200 MG/1.14 ML PEN INJ is a brand product labeled by Sanofi-Aventis U.S. LLC, priced at $2074.9884 per ML under NDC 00024592201. Its NADAC has been published 118 times since May 22, 2024.
Strength
200 mg/1.14mL
Manufacturer
Sanofi-Aventis U.S. LLCNDC
00024592201
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
8/19/2026
Active Ingredients
SARILUMABApproval Type
Biologic (BLA)
FDA Application
BLA761037On Market Since
5/22/2017
Pharmacological Classes
Price Statistics
The NADAC for KEVZARA 200 MG/1.14 ML PEN INJ has been published 118 times since May 22, 2024, and over the history we have for it it has risen 12.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2074.9884 per ML |
|---|---|
| All-time high | $2082.1048 (Jun 10, 2026) |
| All-time low | $1845.7572 (Jul 17, 2024) |
| 52-week high | $2082.1048 |
| 52-week low | $1955.9230 |
| Median price | $1961.5407 |
| Average price | $1962.6938 |
| Largest weekly change | +6.0% (Jan 8, 2025) |
| Weeks tracked | 118 |
| Tracking since | May 22, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of KEVZARA 200 MG/1.14 ML PEN INJ?
The current National Average Drug Acquisition Cost (NADAC) for KEVZARA 200 MG/1.14 ML PEN INJ, manufactured by Sanofi-Aventis U.S. LLC, is $2074.9884 per ML (NDC 00024592201), effective Aug 19, 2026.
How has the price of KEVZARA 200 MG/1.14 ML PEN INJ changed over time?
Over the history we have for it, the NADAC for KEVZARA 200 MG/1.14 ML PEN INJ has risen 12.0%. It has been tracked across 118 weekly CMS publications since May 22, 2024.
What are the highest and lowest recorded NADAC prices for KEVZARA 200 MG/1.14 ML PEN INJ?
Since May 22, 2024, the NADAC for KEVZARA 200 MG/1.14 ML PEN INJ has ranged from a low of $1845.7572 (Jul 17, 2024) to a high of $2082.1048 (Jun 10, 2026), with a median of $1961.5407 per ML.
Are there cheaper alternatives to KEVZARA 200 MG/1.14 ML PEN INJ?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, KEVZARA 200 MG/1.14 ML SYRINGE, is $2066.4821 per ML — about 0% below KEVZARA 200 MG/1.14 ML PEN INJ.
Who manufactures KEVZARA 200 MG/1.14 ML PEN INJ?
KEVZARA 200 MG/1.14 ML PEN INJ (NDC 00024592201) is labeled by Sanofi-Aventis U.S. LLC, and CMS classifies it as a brand product.